hepatitis C virus;
alcoholic beverage;
chronic AODE (alcohol and other drug effects);
amount of AOD use;
epidemiology;
risk factors;
disease course;
alcoholic liver cirrhosis;
gender differences;
biochemical mechanism;
RNA;
mutation;
apoptosis;
inflammation;
hepatocellular carcinoma;
regulatory proteins;
immune response;
alcoholic fatty liver;
treatment issues;
treatment outcome;
interferon;
D O I:
暂无
中图分类号:
R194 [卫生标准、卫生检查、医药管理];
学科分类号:
摘要:
Patients infected with the hepatitis C virus (HCV) who drink heavily are likely to suffer more severe liver injury, promoting disease progression to cirrhosis and increasing their risk for liver cancer. Some research, although not conclusive, suggests that even moderate drinking may spur liver damage in HCV-infected patients. Research areas that have the greatest potential for developing more effective treatment options include HCV virology, immunology, animal models, and the mechanisms of liver injury.
机构:
St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63104 USASt Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63104 USA
机构:
St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63104 USASt Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63104 USA